<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta name="viewport" content="initial-scale=1"><!--[if (mso)|(mso 16)]>
<style type="text/css">a {text-decoration: none;}</style>
<![endif]--><title>Prognosis</title><table id="wrapper" align="center" border="0" cellpadding="0" cellspacing="0" style="max-width: 550px; padding-top: 10px; width: 100%" width="100%">
<!--[if mso]>
<center>
<tr><td>
<table border="0" cellpadding="0" cellspacing="0" width="550">
<![endif]-->
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="brand-hdr">
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9wcm9nbm9zaXM/5daec32c52ba1e0621725115Bb9ae5804">
<!--[if mso]>
<table width="550"><tr><td><img alt="Bloomberg" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/io0pvKRTT7xk/v0/-1x-1.png" width="550" /></td></tr></table>
<div style="display:none">
<![endif]-->
<img class="logo-image" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/io0pvKRTT7xk/v0/-1x-1.png" border="0" alt="Bloomberg" style="width: 100%; max-width: 375px">
<!--[if mso]>
</div>
<![endif]-->
</a>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt"></td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; border-top: 1px dotted #000000; padding-bottom: 1px; padding-top: 0"></td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; border-top: 1px dotted #000000; padding-bottom: 1px; padding-top: 0"></td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; border-top: 1px dotted #000000; padding-bottom: 1px; padding-top: 0"></td>
</tr>
</table>
<table class="social_component" style="width: 100%" width="100%">
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; padding: 0; padding-top: 9px; padding-bottom: 9px; text-transform: uppercase; font-family: Arial; font-size: 12px; font-weight: normal; font-style: normal; font-stretch: normal; line-height: 1.17; letter-spacing: normal; border-right: 10px solid white; border-top: 1px dotted #000000; border-bottom: 1px dotted #000000"><span style="margin-right: 4px;vertical-align: middle">Follow Us</span> <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly93d3cuZmFjZWJvb2suY29tL2Jsb29tYmVyZ2J1c2luZXNzLw/5daec32c52ba1e0621725115B3ff2390d" style="text-decoration: none; color: #000"><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iSTidtzUTVno/v0/-1x-1.png" width="20" height="20" style="vertical-align: middle"> </a><a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly90d2l0dGVyLmNvbS9idXNpbmVzcw/5daec32c52ba1e0621725115B7ed0dd40" style="text-decoration: none; color: #000"><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iD_P6YIGeql4/v0/-1x-1.png" width="20" height="20" style="vertical-align: middle"></a></td>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; padding: 0; padding-top: 9px; padding-bottom: 9px; text-transform: uppercase; font-family: Arial; font-size: 12px; font-weight: normal; font-style: normal; font-stretch: normal; line-height: 1.17; letter-spacing: normal; border-left: 10px solid white; border-top: 1px dotted #000000; border-bottom: 1px dotted #000000">
<a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vam9pbi80d20vcHJvZ25vc2lzLXNpZ251cA/5daec32c52ba1e0621725115Bcb21267f" style="text-decoration: none; color: #000">Get the newsletter</a>
</td>
</tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td class="body-copy bbiz-wysiwyg-content" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 150%; padding: 0 10px">
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">What's harder, making new drugs, or pricing them?</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">Biogen might say it's the former. After scrapping its aducanumab therapy for Alzheimer's in March, the company <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTAtMjIvaG93LWJpb2dlbi1zYWx2YWdlZC1pdHMtYWx6aGVpbWVyLXMtZHJ1Zy1hZnRlci1hLWNvc3RseS1mYWlsdXJlP2NtcGlkPUJCRDEwMjQxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTAyNCZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115B0a078e49" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on Biogen" style="color: #000000"><meta content="PZTEYVDWX2PW" itemprop="suid"><meta content="StoryLink" itemprop="type">reversed course</a> this week and said it will seek approval on the back of some new, more encouraging trial data. A number of drugmakers have been burned in seeking a treatment for the memory-robbing disease, and Biogen was sheared of about a quarter of its market value earlier this year when it looked as though it might join their ranks. The clouds that gathered around Biogen have parted, for now.  </p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">Also tough: figuring out how much to charge for a promising new therapy. Amgen, which currently sells the innovative cholesterol treatment Repatha at two different prices, plans to pull the $14,000 version off the market and only <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTAtMjQvYW1nZW4tcHVsbHMtaGlnaC1wcmljZS12ZXJzaW9uLW9mLXJlcGF0aGEtaW4tYmlkLXRvLXJhaXNlLXNhbGVzP2NtcGlkPUJCRDEwMjQxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTAyNCZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115Ba780a507" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on Amgen" style="color: #000000">offer it</a> for $5,850 a year beginning in 2020. The costlier iteration had struggled to gain traction because patients didn't want to shoulder high co-pays. And the two-price structure faltered because prescription plans didn't like the rebates they got from the discounted one. Amgen thinks one low price will boost sales and help Repatha realize its unmet potential. </p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">Vertex is hoping it has found a sweet spot. This week the biotech company celebrated for developing several groundbreaking drugs got FDA approval—<a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTAtMjEvdmVydGV4LWN5c3RpYy1maWJyb3Npcy1kcnVnLWdldHMtZmRhLWFwcHJvdmFsLWFoZWFkLW9mLXNjaGVkdWxlP2NtcGlkPUJCRDEwMjQxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTAyNCZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115B21faa00f" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on Vertex" style="color: #000000"><meta content="PZQQ53T0AFBE" itemprop="suid"><meta content="StoryLink" itemprop="type">five months early</a>—for a three-drug combo for cystic fibrosis. The news means nearly every patient who suffers from the deadly disease now will have a treatment option. But at $311,503 a year, about $24,000 a month, many will need all the help they can get to pay for it. —<a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly90d2l0dGVyLmNvbS9hbm5ldHRfdGlt/5daec32c52ba1e0621725115Bc1b900ee" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Tim Annett on Twitter" style="color: #000000"><meta content="WebLink" itemprop="type"><em>Tim Annett</em></a></p>
<h2 style="line-height: 26px; font-family: Helvetica, Arial Black, Arial, sans-serif; color: #000000; font-weight: bold; margin-top: 5px; margin-bottom: 20px; font-size: 24px">Here's what else we're watching:</h2>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Opioid brawl.</strong> About $50 billion in settlement offers have <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTAtMjEvZHJ1Zy13aG9sZXNhbGVycy10ZXZhLXNldHRsZS13aXRoLW9oaW8tY291bnRpZXMtaW4tb3Bpb2lkLWNhc2U_Y21waWQ9QkJEMTAyNDE5X1BST0cmdXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX3Rlcm09MTkxMDI0JnV0bV9jYW1wYWlnbj1wcm9nbm9zaXM/5daec32c52ba1e0621725115B036a1520" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on opioids" style="color: #000000"><meta content="PZRTHIDWLU75" itemprop="suid"><meta content="StoryLink" itemprop="type">sparked a fight</a> between states and local governments over how much the pharmaceutical industry should pay for its role in creating the U.S. opioid epidemic.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Powder problems.</strong> Johnson &amp; Johnson recalled one lot of baby powder after <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTAtMTgvai1qLXJlY2FsbHMtc2luZ2xlLWxvdC1vZi1iYWJ5LXBvd2Rlci1hZnRlci1hc2Jlc3Rvcy10cmFjZS1mb3VuZD9jbXBpZD1CQkQxMDI0MTlfUFJPRyZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9bmV3c2xldHRlciZ1dG1fdGVybT0xOTEwMjQmdXRtX2NhbXBhaWduPXByb2dub3Npcw/5daec32c52ba1e0621725115Bde42c72d" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on powder recall" style="color: #000000"><meta content="PZLB0DT1UM0X" itemprop="suid"><meta content="StoryLink" itemprop="type">tiny amounts</a> of asbestos contamination were found in samples from a single bottle. The company is battling lawsuits over cancer claims.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Vaping crackdown. </strong>The FDA said a New Jersey company used illegal marketing tactics to push its products. Eonsmoke's wares, which the company says work with Juul, were touted by social-media influencers.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Cancer confrontation.</strong> Merck came up with the <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTAtMjIvbWVyY2stc2hlZHMtMTAtYmlsbGlvbi1hcy1icmlzdG9sLW15ZXJzLXN0dWR5LWRlbnRzLWV1cGhvcmlhP2NtcGlkPUJCRDEwMjQxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTAyNCZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115B6882d503" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on Merck" style="color: #000000"><meta content="PZSB9TDWLU6A" itemprop="suid"><meta content="StoryLink" itemprop="type">short end</a> this week in its ongoing immunotherapy face-off with Bristol-Myers, after strong data on the latter's Opdivo raised a threat to Keytruda's lung-cancer dominance.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Listen up.</strong> Many antibiotics we’ve relied on for decades to treat infections no longer work. It’s a global crisis. But where do superbugs come from? In our final episode of this season’s Prognosis podcast, Bloomberg Senior Editor Jason Gale introduces a scientist searching for clues. Download it <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly9pdHVuZXMuYXBwbGUuY29tL3VzL3BvZGNhc3QvcHJvZ25vc2lzL2lkMTQ0MDA1MTA4Nj9tdD0yP3NybmQ9cHJvZ25vc2lzLXBvZGNhc3Q/5daec32c52ba1e0621725115B9c7da428" itemprop="StoryLink" itemscope="itemscope" target="_blank" style="color: #000000">here</a> on Apple devices, and here on <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly9wbGF5Lmdvb2dsZS5jb20vbXVzaWMvbGlzdGVuP3U9MCMvcHMvSWZidXdwNGZyamxtczR3eXducW51Ymh5cmNh/5daec32c52ba1e0621725115Ba2deac3e" itemprop="StoryLink" itemscope="itemscope" title="Android download link" style="color: #000000">Android</a>.</p>
<!--[if mso]>
<table width="550"><tr><td><img alt="" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iCN..I4Ldqog/v0/-1x-1.jpg" width="550" /></td></tr></table>
<div style="display:none">
<![endif]-->
<img alt="" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iCN..I4Ldqog/v0/-1x-1.jpg" style="display: block; margin: auto; width: 100%">
<!--[if mso]>
</div>
<![endif]-->
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">
<em>Got this newsletter forwarded to you? Sign up to get it every Thursday by <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vam9pbi80d20vcHJvZ25vc2lzLXNpZ251cD9zb3VyY2U9YXJ0aWNsZQ/5daec32c52ba1e0621725115C7459bd0a" itemprop="StoryLink" itemscope="itemscope" style="color: #000000">clicking here</a>. <br><br>We want to hear from you. If you have feedback, questions or potential story ideas, reach out to me at <a href="mailto:tannett@bloomberg.net" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Email to Tim Annett" style="color: #000000">tannett@bloomberg.net</a></em>
</p>
</td>
</tr>
</table>
<table>
<tbody>
<tr>
<td height="20"> </td>
</tr>
<tr>
<td class="bbiz-wysiwyg-content tout-label"></td>
</tr>
<tr>
<td class="bbiz-wysiwyg-content tout-text"><p><strong>Like Bloomberg’s Prognosis?</strong> <em>Subscribe to Bloomberg.com. You’ll get our unmatched global news coverage and two premium daily newsletters, The Bloomberg Open and The Bloomberg Close, and much, much more. See our <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9zdWJzY3JpcHRpb25zP3V0bV9zb3VyY2U9bmV3c2xldHRlciZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1ldmVuaW5nYnJpZWYmdXRtX3Rlcm09WVlNTURE/58091eb2b84a994a148b4b20Be63e5877">limited-time introductory offer</a>.</em></p>
<p><strong>Download the Bloomberg app:</strong> <em>It’s available <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vY2xpY2svMTAyNzYwMTcuMTgzNTczL2FIUjBjSE02THk5cGRIVnVaWE11WVhCd2JHVXVZMjl0TDJGd2NDOWhjSEJzWlMxemRHOXlaUzlwWkRJNE1UazBNVEE1Tno5d2REMDRPVFE1Sm1OMFBYSmxiR0YxYm1Ob1gyVnRZV2xzSm0xMFBUZy81NmZiZWNjMWU5YThhMjQxMDc4YjQ4YjFCOWU2MDcyNDE/58091eb2b84a994a148b4b20B42849805">for iOS</a> and <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vY2xpY2svMTAyNzYwMTcuMTgzNTczL2FIUjBjSE02THk5d2JHRjVMbWR2YjJkc1pTNWpiMjB2YzNSdmNtVXZZWEJ3Y3k5a1pYUmhhV3h6UDJsa1BXTnZiUzVpYkc5dmJXSmxjbWN1WVc1a2NtOXBaQzV3YkhWekpuSmxabVZ5Y21WeVBYVjBiVjl6YjNWeVkyVWxNMFJsYldGcGJDVXlOblYwYlY5allXMXdZV2xuYmlVelJISmxiR0YxYm1Oby81NmZiZWNjMWU5YThhMjQxMDc4YjQ4YjFCNDMwMDQ2ODA/58091eb2b84a994a148b4b20Bc061af45">Android</a>.</em></p>
<p><em>Before it's here, it's on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can't find anywhere else. <a href="https://link.mail.bloombergbusiness.com/click/15638356.78421/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9wcm9mZXNzaW9uYWwvc29sdXRpb24vYmxvb21iZXJnLXRlcm1pbmFsLw/55088ec43b35d034698d38aeBe3d4e6ab">Learn more</a>.</em></p></td>
</tr>
<tr>
<td height="20"> </td>
</tr>
</tbody>
</table>
<table id="footer" width="100%" align="center" border="0" cellpadding="0" cellspacing="0">
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666; padding-bottom: 10px">You received this message because you are subscribed to Bloomberg's Prognosis newsletter.</td>
</tr>
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666"><a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cHM6Ly9sb2dpbi5ibG9vbWJlcmcuY29tL25ld3NsZXR0ZXJzP3NvdXJjZT1uZXdzbGV0dGVyX3Vuc3ViJmVtYWlsPXB1Ymxpc2gtYmxvb21iZXJnJTQwZW1tYXJlcy5uZXQmaGFzaD1kMTYxYmU4YmU0ZTUyNzFlMGMwZTMzMThiYWVhNjg1Yg/5daec32c52ba1e0621725115B76723890" style="color: #666666; text-decoration: none" alias="  | <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cDovL2Jsb29tYmVyZy5jb20/5daec32c52ba1e0621725115B46ca7e14" style="color: #666666; text-decoration: none" target="_blank">Bloomberg.com</a> | <a href="https://link.mail.bloombergbusiness.com/click/18424906.4484/aHR0cDovL3d3dy5ibG9vbWJlcmcuY29tL2ZlZWRiYWNrP2FsY21waWQ9bW9zdHBvcA/5daec32c52ba1e0621725115Bc48dc602" style="color: #666666; text-decoration: none" target="_blank">Contact Us</a></td>
</tr>
<tr>
<td height="20" align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666">Bloomberg L.P. 731 Lexington, New York, NY, 10022</td>
</tr>
</table>
<!--[if mso]>
</td></tr>
</table>
</center>
<![endif]-->
</td>
</tr>
</table><custom name="opencounter" type="tracking"><a href=""><img src="https://link.mail.bloombergbusiness.com/img/5daec32c52ba1e0621725115aywqy.3gk/8290f161.gif" alt="" border="0"></a></custom>